Sara Beygi

1.4k total citations
34 papers, 779 citations indexed

About

Sara Beygi is a scholar working on Oncology, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Sara Beygi has authored 34 papers receiving a total of 779 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 18 papers in Pathology and Forensic Medicine and 9 papers in Immunology. Recurrent topics in Sara Beygi's work include CAR-T cell therapy research (17 papers), Lymphoma Diagnosis and Treatment (13 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Sara Beygi is often cited by papers focused on CAR-T cell therapy research (17 papers), Lymphoma Diagnosis and Treatment (13 papers) and Cutaneous lymphoproliferative disorders research (3 papers). Sara Beygi collaborates with scholars based in United States, United Kingdom and Iran. Sara Beygi's co-authors include Vafa Rahimi‐Movaghar, Seyed Behzad Jazayeri, Vahide Lajevardi, Farhad Shokraneh, Robabeh Abedini, Ellen Merete Hagen, James S. Harrop, George M. Ghobrial, Mohammad Salehi and Joshua Heller and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sara Beygi

31 papers receiving 760 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Beygi United States 15 332 193 158 121 112 34 779
Susanna Maddali Bongi Italy 18 376 1.1× 163 0.8× 92 0.6× 122 1.0× 133 1.2× 45 910
Gemma Lepri Italy 17 375 1.1× 63 0.3× 94 0.6× 41 0.3× 145 1.3× 51 604
Uriel Katz Israel 15 170 0.5× 114 0.6× 326 2.1× 44 0.4× 41 0.4× 34 1.0k
Francis Guillemin France 15 847 2.6× 115 0.6× 90 0.6× 88 0.7× 88 0.8× 28 1.1k
Marina Anderson United Kingdom 20 795 2.4× 217 1.1× 270 1.7× 79 0.7× 378 3.4× 30 1.3k
Samu Kurki Finland 17 161 0.5× 77 0.4× 68 0.4× 230 1.9× 28 0.3× 47 742
Ulrich Seidel Germany 13 117 0.4× 173 0.9× 48 0.3× 32 0.3× 72 0.6× 28 693
Niveditha Mohan United States 8 164 0.5× 69 0.4× 235 1.5× 55 0.5× 40 0.4× 15 1.0k
Jelena Kostić Serbia 12 270 0.8× 84 0.4× 36 0.2× 76 0.6× 57 0.5× 36 543
Leo H. Visser Netherlands 23 342 1.0× 647 3.4× 174 1.1× 201 1.7× 26 0.2× 42 1.7k

Countries citing papers authored by Sara Beygi

Since Specialization
Citations

This map shows the geographic impact of Sara Beygi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Beygi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Beygi more than expected).

Fields of papers citing papers by Sara Beygi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Beygi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Beygi. The network helps show where Sara Beygi may publish in the future.

Co-authorship network of co-authors of Sara Beygi

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Beygi. A scholar is included among the top collaborators of Sara Beygi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Beygi. Sara Beygi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kanters, Steve, Sara Beygi, Timothy Best, et al.. (2024). Matching-Adjusted Indirect Comparisons of Axicabtagene Ciloleucel to Mosunetuzumab for the Treatment of Relapsed/Refractory Follicular Lymphoma. Transplantation and Cellular Therapy. 30(9). 885.e1–885.e11. 2 indexed citations
3.
Ghione, Paola, M. Lia Palomba, Eve H. Limbrick‐Oldfield, et al.. (2024). A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ciloleucel) With SCHOLAR-5 in Relapsed/Refractory Follicular Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 24(5). e191–e195.e6.
4.
5.
Ray, M. D., Steve Kanters, Sara Beygi, et al.. (2023). Matching‐adjusted indirect comparison of axicabtagene ciloleucel versus mosunetuzumab in relapsed/refractory follicular lymphoma patients after 2 prior systemic treatments. Hematological Oncology. 41(S2). 522–523. 3 indexed citations
6.
Shree, Tanaya, Vishnu Shankar, Debra K. Czerwinski, et al.. (2022). CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished Immunity. Blood Cancer Discovery. 3(2). 95–102. 27 indexed citations
7.
Ghione, Paola, M. Lia Palomba, Hervé Ghesquières, et al.. (2022). Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study. Haematologica. 108(3). 822–832. 21 indexed citations
8.
Ghione, Paola, Maria Lia Palomba, Eve H. Limbrick‐Oldfield, et al.. (2022). A 3-Year Follow-up Comparison of Clinical Outcomes from Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma (R/R FL). Blood. 140(Supplement 1). 4676–4677. 2 indexed citations
9.
Sworder, Brian J., David M. Kurtz, Charles Macaulay, et al.. (2019). Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy. Blood. 134(Supplement_1). 550–550. 14 indexed citations
10.
Ghobrial, George M., et al.. (2016). Improved patient quality of life following intradural extramedullary spinal tumor resection. Journal of Neurosurgery Spine. 25(5). 640–645. 31 indexed citations
11.
Lajevardi, Vahide, et al.. (2015). Comparison of Systemic Mycophenolate Mofetil with Topical Clobetasol in Lichen Planopilaris: A Parallel-Group, Assessor- and Analyst-Blinded, Randomized Controlled Trial. American Journal of Clinical Dermatology. 16(4). 303–311. 32 indexed citations
12.
Ghobrial, George M., Sara Beygi, Joshua Heller, et al.. (2015). C-5 palsy after cerebrospinal fluid diversion in posttraumatic syringomyelia: case report. Journal of Neurosurgery Spine. 22(4). 394–398. 1 indexed citations
13.
Najafabadi, Mahboubeh Ghayour, et al.. (2015). Does Ramadan Fasting Adversely Affect Cognitive Function in Young Females?. Scientifica. 2015. 1–6. 18 indexed citations
14.
Abedini, Robabeh, Mohammad Salehi, Vahide Lajevardi, & Sara Beygi. (2015). Patients with psoriasis are at a higher risk of developing nonalcoholic fatty liver disease. Clinical and Experimental Dermatology. 40(7). 722–727. 68 indexed citations
15.
Ghobrial, George M., Sara Beygi, Christopher M. Maulucci, et al.. (2015). Surgical Management in 40 Consecutive Patients With Cervical Spinal Epidural Abscesses. Spine. 40(17). E949–E953. 27 indexed citations
16.
Ghobrial, George M., Sara Beygi, Christopher M. Maulucci, et al.. (2014). Timing in the surgical evacuation of spinal epidural abscesses. Neurosurgical FOCUS. 37(2). E1–E1. 46 indexed citations
17.
Jazayeri, Seyed Behzad, Sara Beygi, Farhad Shokraneh, Ellen Merete Hagen, & Vafa Rahimi‐Movaghar. (2014). Incidence of traumatic spinal cord injury worldwide: a systematic review. European Spine Journal. 24(5). 905–918. 241 indexed citations
18.
Ghobrial, George M., Christopher M. Maulucci, Sara Beygi, et al.. (2014). Suture Choice in Lumbar Dural Closure Contributes to Variation in Leak Pressures: Experimental Model. Clinical Spine Surgery A Spine Publication. 30(6). 272–275. 10 indexed citations
19.
Beygi, Sara, Soheil Saadat, Seyed Behzad Jazayeri, & Vafa Rahimi‐Movaghar. (2013). Epidemiology of pediatric primary malignant central nervous system tumors in Iran: A 10 year report of National Cancer Registry. Cancer Epidemiology. 37(4). 396–401. 25 indexed citations
20.
Memari, Amir Hossein, Vahid Ziaee, Sara Beygi, Pouria Moshayedi, & Fatemeh Sadat Mirfazeli. (2011). Overuse of psychotropic medications among children and adolescents with autism spectrum disorders: Perspective from a developing country. Research in Developmental Disabilities. 33(2). 563–569. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026